甲状腺支持补充剂市场机会、成长驱动因素、产业趋势分析及预测（2025-2034年）

2024 年全球甲状腺支持补充剂市场价值为 20 亿美元，预计到 2034 年将以 9.2% 的复合年增长率增长至 48 亿美元。

全球数百万人患有甲状腺疾病，推动了营养和草药支持解决方案的需求成长，也促进了甲状腺支持产品的市场扩张。消费者越来越倾向于选择成分纯净、植物性和天然配方的产品，反映出人们健康意识的增强。碘缺乏症和自体免疫甲状腺疾病（如桥本氏甲状腺炎）病例的增加，进一步刺激了对标靶补充剂的需求。补充剂技术的进步，包括缓释胶囊和协同营养混合物，提高了吸收率、依从性和有效性。甲状腺支持补充剂涵盖多种产品，包括碘基溶液、适应原草药、特殊氨基酸和综合复合维生素。它们支持荷尔蒙生成、代谢调节和能量平衡，并受到全球卫生机构的监管，以确保安全性和品质。补充剂有胶囊、片剂、粉末和液体等多种剂型，以满足不同消费者的需求。

预计到2034年，线下市场规模将达到29亿美元，在2025年至2034年期间将以9%的显着复合年增长率增长，这主要得益于消费者对即时医疗服务需求的不断增长以及线下场所提供先进治疗服务的便利。该市场进一步细分为药房和药局、超市和大型超市以及其他线下零售网点。线下管道具有诸多优势，例如药剂师的直接指导、产品的即时供应以及强大的品牌知名度，尤其对于广泛使用的、专业级的甲状腺补充剂而言更是如此。

2024年，甲状腺功能低下症市场占据了62.1%的份额，这主要得益于甲状腺功能低下症盛行率的不断上升，尤其是在女性和老年人群中。这个市场占据主导地位的原因在于消费者对相关产品的广泛接受，以及人们对甲状腺功能障碍引起的疲劳、体重增加和情绪障碍等问题的认识不断提高，同时，消费者也越来越倾向于选择天然的非处方替代疗法来代替传统的激素疗法。甲状腺功能减退症的补充剂通常包含碘、硒、L-酪胺酸、锌等营养成分以及一些适应原草药，以支持荷尔蒙的合成、转化和免疫调节。

北美甲状腺保健品市场预计在2024年占据43.5%的市场份额，主要受甲状腺疾病和碘缺乏症高发生率的推动。该地区拥有完善的医疗保健基础设施，且消费者对预防性营养的意识日益增强，这些优势使其受益匪浅。随着基因组分析和人工智慧驱动的营养补充指导等个人化营养方法被越来越多地应用于精准医疗和改善长期健康状况，北美各国对市场需求的贡献显着。

全球甲状腺支持补充剂市场的主要公司包括 Designs for Health、Thorne Research、NOW Foods、Native Remedies、Pure Encapsulations、Wellness Resources、LES Labs、Solaray、Nutrisage、Douglas Laboratories、VitaStrength、Dr. Westin Childs、Dr. Jolene Brighten、Douglas Laboratories、VitaStrength、Dr. Westin Childs、Dr。 Nutrition 和 ThyrAid。为了巩固市场地位，甲状腺支持补充剂行业的公司正在实施多项策略。他们加大研发投入，致力于研发高生物利用度、植物性、缓释型补充剂，以增强甲状腺功能。与医疗保健机构、营养师和健康平台进行策略合作，有助于扩大产品覆盖范围，并提升消费者信任度。各公司专注于个人化营养解决方案，整合人工智慧驱动的建议和基因组分析，以提供针对性的支援。

目录

第一章：方法论与范围

第二章：执行概要

第三章：行业洞察

• 产业生态系分析
  • 供应商格局
  • 每个阶段的价值增加
  • 影响价值链的因素
• 产业影响因素
  • 成长驱动因素
    • 甲状腺疾病盛行率不断上升
    • 生活方式和饮食失衡
    • 膳食补充配方方面的进展
    • 日益增强的健康意识和预防保健重点
  • 产业陷阱与挑战
    • 部分产品缺乏临床验证
    • 监管和品质问题
  • 市场机会
    • 个人化营养和人工智慧驱动的健康领域的创新
    • 扩大植物基和清洁标籤配方
• 成长潜力分析
• 监管环境
• 未来市场趋势
• 技术格局
  • 目前技术
  • 新兴技术
• 定价分析
• 报销方案
• 波特的分析
• PESTEL 分析

第四章：竞争格局

• 介绍
• 公司市占率分析
• 公司矩阵分析
• 主要市场参与者的竞争分析
• 竞争定位矩阵
• 关键进展
  • 併购
  • 伙伴关係与合作
  • 新产品发布
  • 扩张计划

第五章：市场估算与预测：依类型划分，2021-2034年

• 主要趋势
• 甲状腺功能亢进
• 甲状腺功能低下症

第六章：市场估算与预测：依产品类型划分，2021-2034年

• 主要趋势
• 片剂
• 胶囊
• 液体
• 其他产品类型

第七章：市场估计与预测：依成分划分，2021-2034年

• 主要趋势
• 维生素和矿物质
• 草药萃取物
• 胺基酸
• 其他成分

第八章：市场估算与预测：依年龄组别划分，2021-2034年

• 主要趋势
• 儿科
• 成年人
• 老年医学

第九章：市场估算与预测：依配销通路划分，2021-2034年

• 主要趋势
• 在线的
• 离线
  • 药房和药品商店
  • 超市/大型超市
  • 其他线下门市

第十章：市场估计与预测：依地区划分，2021-2034年

• 主要趋势
• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 英国
  • 法国
  • 西班牙
  • 义大利
  • 荷兰
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 澳洲
  • 韩国
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
• 中东和非洲
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋

第十一章：公司简介

• 1 Body
• Designs for Health
• Douglas Laboratories
• Dr. Jolene Brighten
• Dr. Westin Childs
• Integrative Therapeutics
• LES Labs
• MaryRuth Organics
• Metabolic Nutrition
• Native Remedies
• Nature Made
• NOW Foods
• Nutrisage
• Pure Encapsulations
• Solaray
• Strong Nature
• Thorne Research
• ThyrAid
• VitaStrength
• Wellness Resources

The Global Thyroid Support Supplements Market was valued at USD 2 billion in 2024 and is estimated to grow at a CAGR of 9.2% to reach USD 4.8 billion by 2034.

The expansion is driven by the increasing prevalence of thyroid disorders affecting millions worldwide, which is fueling demand for nutritional and herbal support solutions. Consumer interest is shifting toward clean-label, plant-based, and natural formulations, reflecting growing health consciousness. Rising cases of iodine deficiency and autoimmune thyroid disorders, such as Hashimoto's disease, are further boosting demand for targeted supplements. Advancements in supplement technology, including sustained-release capsules and synergistic nutrient blends, are enhancing absorption, compliance, and effectiveness. Thyroid support supplements encompass a wide array of products, including iodine-based solutions, adaptogenic herbs, specialty amino acids, and comprehensive multivitamins. They support hormone production, metabolic regulation, and energy balance, while being regulated by global health authorities to ensure safety and quality. Supplements are available in capsules, tablets, powders, and liquids to meet diverse consumer preferences.

The offline segment is projected to reach USD 2.9 billion by 2034, growing at a notable CAGR of 9% during 2025-2034, driven by the rising demand for immediate care and the availability of advanced therapeutic services in physical locations. This segment is further divided into pharmacies and drug stores, supermarkets and hypermarkets, as well as other offline retail outlets. Offline channels offer advantages such as direct pharmacist guidance, instant product availability, and strong brand visibility, especially for widely used and practitioner-grade thyroid supplements.

The hypothyroidism segment accounted for a 62.1% share in 2024, fueled by the growing prevalence of underactive thyroid conditions, especially among women and aging populations. This segment dominates due to widespread consumer adoption, rising awareness of fatigue, weight gain, and mood disorders linked to thyroid dysfunction, and the increasing preference for natural, non-prescription alternatives to conventional hormone therapy. Supplements targeting hypothyroidism typically include nutrients such as iodine, selenium, L-tyrosine, zinc, and adaptogenic herbs to support hormone synthesis, conversion, and immune regulation.

North America Thyroid Support Supplements Market held a 43.5% share in 2024, driven by a high incidence of thyroid disorders and iodine deficiency. The region benefits from a strong healthcare infrastructure and growing consumer awareness of preventive nutrition. Countries within the region significantly contribute to market demand, as personalized nutrition approaches, including genomic profiling and AI-driven supplement guidance, are increasingly adopted to enhance precision care and long-term health outcomes.

Prominent companies in the Global Thyroid Support Supplements Market include Designs for Health, Thorne Research, NOW Foods, Native Remedies, Pure Encapsulations, Wellness Resources, LES Labs, Solaray, Nutrisage, Douglas Laboratories, VitaStrength, Dr. Westin Childs, Dr. Jolene Brighten, MaryRuth Organics, Strong Nature, Integrative Therapeutics, Nature Made, 1 Body, Metabolic Nutrition, and ThyrAid.To strengthen their position, companies in the thyroid support supplements industry are implementing multiple strategies. They are investing in research and development to formulate highly bioavailable, plant-based, and sustained-release supplements that enhance thyroid function. Strategic collaborations with healthcare providers, nutritionists, and wellness platforms help expand product reach and consumer trust. Companies are focusing on personalized nutrition solutions, integrating AI-driven recommendations, and genomic profiling to offer targeted support.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Data mining sources
  • 1.3.1 Global
  • 1.3.2 Regional/country
• 1.4 Base estimates and calculations
  • 1.4.1 Base year calculation
  • 1.4.2 Key trends for market estimation
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
• 1.6 Forecast model
• 1.7 Research assumption and limitations

Chapter 2 Executive Summary

• 2.1 Industry 360⁰ synopsis
• 2.2 Key market trends
  • 2.2.1 Regional trends
  • 2.2.2 Type trends
  • 2.2.3 Product type trends
  • 2.2.4 Ingredient trends
  • 2.2.5 Age group trends
  • 2.2.6 Distribution channel trends
• 2.3 CXO perspectives: Strategic imperatives
  • 2.3.1 Key decision points for industry executives
  • 2.3.2 Critical success factors for market players
• 2.4 Future outlook and strategic recommendations

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
  • 3.1.1 Supplier landscape
  • 3.1.2 Value addition at each stage
  • 3.1.3 Factor affecting the value chain
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increasing prevalence of thyroid disorders
    • 3.2.1.2 Lifestyle and dietary imbalances
    • 3.2.1.3 Advancements in supplement formulations
    • 3.2.1.4 Growing awareness and preventive health focus
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 Lack of clinical validation for some products
    • 3.2.2.2 Regulatory and quality concerns
  • 3.2.3 Market opportunities
    • 3.2.3.1 Innovation in personalized nutrition and AI-driven wellness
    • 3.2.3.2 Expansion of plant-based and clean-label formulations
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
  • 3.4.1 North America
  • 3.4.2 Europe
  • 3.4.3 Asia Pacific
  • 3.4.4 Latin America
  • 3.4.5 Middle East and Africa
• 3.5 Future market trends
• 3.6 Technological landscape
  • 3.6.1 Current technologies
  • 3.6.2 Emerging technologies
• 3.7 Pricing analysis
• 3.8 Reimbursement scenario
• 3.9 Porter's analysis
• 3.10 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Company matrix analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Key developments
  • 4.6.1 Merger and acquisition
  • 4.6.2 Partnership and collaboration
  • 4.6.3 New product launches
  • 4.6.4 Expansion plans

Chapter 5 Market Estimates and Forecast, By Type, 2021 - 2034 ($ Mn)

• 5.1 Key trends
• 5.2 Hyperthyroidism
• 5.3 Hypothyroidism

Chapter 6 Market Estimates and Forecast, By Product Type, 2021 - 2034 ($ Mn)

• 6.1 Key trends
• 6.2 Tablets
• 6.3 Capsules
• 6.4 Liquids
• 6.5 Other product types

Chapter 7 Market Estimates and Forecast, By Ingredient, 2021 - 2034 ($ Mn)

• 7.1 Key trends
• 7.2 Vitamins and minerals
• 7.3 Herbal extracts
• 7.4 Amino acids
• 7.5 Other ingredients

Chapter 8 Market Estimates and Forecast, By Age Group, 2021 - 2034 ($ Mn)

• 8.1 Key trends
• 8.2 Pediatric
• 8.3 Adults
• 8.4 Geriatric

Chapter 9 Market Estimates and Forecast, By Distribution Channel, 2021 - 2034 ($ Mn)

• 9.1 Key trends
• 9.2 Online
• 9.3 Offline
  • 9.3.1 Pharmacies and drug stores
  • 9.3.2 Supermarkets/ hypermarkets
  • 9.3.3 Other offline stores

Chapter 10 Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn)

• 10.1 Key trends
• 10.2 North America
  • 10.2.1 U.S.
  • 10.2.2 Canada
• 10.3 Europe
  • 10.3.1 Germany
  • 10.3.2 UK
  • 10.3.3 France
  • 10.3.4 Spain
  • 10.3.5 Italy
  • 10.3.6 Netherlands
• 10.4 Asia Pacific
  • 10.4.1 China
  • 10.4.2 Japan
  • 10.4.3 India
  • 10.4.4 Australia
  • 10.4.5 South Korea
• 10.5 Latin America
  • 10.5.1 Brazil
  • 10.5.2 Mexico
  • 10.5.3 Argentina
• 10.6 Middle East and Africa
  • 10.6.1 South Africa
  • 10.6.2 Saudi Arabia
  • 10.6.3 UAE

Chapter 11 Company Profiles

• 11.1 1 Body
• 11.2 Designs for Health
• 11.3 Douglas Laboratories
• 11.4 Dr. Jolene Brighten
• 11.5 Dr. Westin Childs
• 11.6 Integrative Therapeutics
• 11.7 LES Labs
• 11.8 MaryRuth Organics
• 11.9 Metabolic Nutrition
• 11.10 Native Remedies
• 11.11 Nature Made
• 11.12 NOW Foods
• 11.13 Nutrisage
• 11.14 Pure Encapsulations
• 11.15 Solaray
• 11.16 Strong Nature
• 11.17 Thorne Research
• 11.18 ThyrAid
• 11.19 VitaStrength
• 11.20 Wellness Resources